PUBLISHER: The Business Research Company | PRODUCT CODE: 1939357
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939357
Biotechnology instruments are specialized tools and equipment used in biotechnology laboratories to carry out research, develop products, and perform biological processes. They are essential for manipulating biological systems and advancing fields such as medicine, agriculture, and environmental science.
The main categories of biotechnology instruments include lab automation instruments, life science consumables, and in vitro diagnostic (IVD) instruments. Lab automation instruments are advanced systems developed to carry out repetitive laboratory operations with minimal manual involvement. These instruments are used in applications such as clinical diagnostics, drug discovery and development, proteomics, genomics, cell analysis, and others, and are employed by end users including pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, academic institutions, and research organizations.
Tariffs are impacting the biotechnology instruments market by increasing costs for imported lab automation systems, reagents, and diagnostic equipment. Segments like robotic liquid handlers, automated plate readers, and molecular diagnostic instruments are most impacted, with Asia-Pacific regions including China and India experiencing significant import duties. While tariffs have raised production and procurement costs, they have also encouraged local manufacturing, investment in domestic production, and innovation in cost-effective instrumentation solutions.
The biotechnology instruments market research report is one of a series of new reports from The Business Research Company that provides biotechnology instruments market statistics, including biotechnology instruments industry global market size, regional shares, competitors with a biotechnology instruments market share, detailed biotechnology instruments market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology instruments industry. This biotechnology instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biotechnology instruments market size has grown strongly in recent years. It will grow from $80.9 billion in 2025 to $86.43 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to limited automation in biotechnology labs, dependence on manual sample processing, growing pharmaceutical and biotech research, adoption of conventional diagnostic instruments, increasing demand for laboratory consumables.
The biotechnology instruments market size is expected to see strong growth in the next few years. It will grow to $111.27 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to development of advanced lab automation instruments, integration of ai and robotics in research workflows, expansion of genomics and proteomics studies, rising investment in pharmaceutical r&d, adoption of cloud-based data management solutions. Major trends in the forecast period include increasing adoption of lab automation instruments, rising demand for high-throughput screening and analysis, expansion of proteomics and genomics research, growing use of ivd instruments in clinical diagnostics, enhanced focus on quality control and regulatory compliance.
The growing prevalence of chronic diseases is expected to propel the growth of the biotechnology instruments market going forward. Chronic diseases, also referred to as chronic conditions or chronic illnesses, are long-term health issues that typically persist for three months or longer. The prevalence of chronic diseases is influenced by unhealthy lifestyle choices, an aging population, and improved awareness and diagnostic capabilities. Biotechnology instruments contribute to improving patient quality of life by enhancing diagnostic accuracy, optimizing treatment approaches, and enabling effective disease management. These instruments also support the identification of potential drug candidates and facilitate the understanding of their impact on chronic diseases. For example, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia, or pre-diabetes-a condition characterized by elevated blood sugar levels that are not high enough to be classified as diabetes-in 2023. This represented an 18% increase from 3,065,825 cases recorded in 2022. Therefore, the rising burden of chronic diseases is driving the growth of the biotechnology instruments market.
Leading companies operating in the biotechnology instruments market are focused on developing innovative products, such as single-cell multi-omics solutions, to advance personalized medicine and support genomics, proteomics, and metabolomics research. Single-cell multi-omics solutions are advanced technologies that enable simultaneous analysis of multiple biological data layers from individual cells, including genomics, transcriptomics, proteomics, and metabolomics. For example, in June 2023, Singleron Biotechnologies, a Germany-based biotechnology company, launched two advanced instruments, the NEO and the Python Junior, to improve standardization across single-cell analysis workflows. The NEO system supports processing of up to half a million cells in a single run across four independent channels, while the Python Junior focuses on efficient dissociation of solid tissues into high-quality single-cell suspensions.
In January 2024, Calibre Scientific, a US-based company engaged in the manufacturing and supply of high-quality laboratory instruments, acquired LabTech S.r.l. for an undisclosed amount. With this acquisition, Calibre Scientific aims to enhance its position in the life sciences sector by expanding its portfolio of laboratory instruments and consumables. LabTech S.r.l. is a UK-based company that manufactures biotechnology instruments, including centrifuges, shakers, incubators, and pipetting systems.
Major companies operating in the biotechnology instruments market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Merck KGaA, Quest Diagnostics Inc., Avantor Inc., Agilent Technologies, Illumina Inc., Sartorius AG, Mettler Toledo, Perkin Elmer Inc., Shimadzu Corporation, Bruker Corporation, Zeiss Group, QIAGEN N.V., Novanta Inc., Cynosure LLC, Bio-Rad Laboratories Inc, Ori Biotech Limited, Hudson Robotics
North America was the largest region in the biotechnology instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the biotechnology instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The biotechnology instruments market consists of sales of micropipettes, incubators, and autoclaves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biotechnology Instruments Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses biotechnology instruments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for biotechnology instruments ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biotechnology instruments market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.